Literature DB >> 29914244

Human immunodeficiency virus and tuberculosis coinfection: clinical features and zzm321990predictors of mortality

Fatma Gümüşer, Merve Altınkaynak, Dilek Yıldız Sevgi, Özlem Altuntaş Aydın, Bilgül Mete, Alper Gündüz, Hayat Kumbasar Karaosmanoğlu, Sibel Bolukçu, Ömer Fehmi Tabak, Mustafa Haluk Vahaboğlu.   

Abstract

Background/aim: This study was undertaken to identify subjects with human immunodeficiency virus and tuberculosis (HIV/TB) coinfection in a group of HIV-positive patients followed at five different healthcare centers, and to determine the demographic and clinical characteristics of these subjects as well as the predictors of mortality. Materials and methods: A database search for subjects with TB coinfection was performed among 1475 HIV-positive adult patients and a total of 66 individuals were identified with HIV/TB coinfection.
Results: There were 66 patients (4.5%) with TB coinfection. Twenty-one percent (n = 14) of the patients with TB coinfection died during the study period and these patients had significantly lower baseline CD4 counts at the time of TB diagnosis (P = 0.005). None of the patients with CD4 count of ≥200 cells/mm3 died during follow-up and a low CD4 count at the time of TB diagnosis (<200 cells/ mm3) was associated with poor survival (P = 0.012). However, none of the parameters emerged as significant independent predictors of survival in multivariate analysis.
Conclusion: Coexistence of TB and HIV infection is associated with many clinical challenges and a better understanding of patient characteristics as well as the parameters impacting the outcome will improve the quality of care provided for this group of patients.

Entities:  

Keywords:  Human immunodeficiency virus; tuberculosis; coinfection; mortality

Year:  2018        PMID: 29914244     DOI: 10.3906/sag-1706-76

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  Predictors for tuberculosis co-infection in people living with HIV/AIDs.

Authors:  Esra Zerdali; İnci Yılmaz Nakir; Serkan Sürme; Uğurcan Sayılı; Mustafa Yıldırım
Journal:  Afr Health Sci       Date:  2021-09       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.